A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS

被引:25
作者
Hilleman, MR [1 ]
机构
[1] Merck Inst Therapeut Res, Merck Res Labs, W Point, PA 19486 USA
关键词
simplified vaccinology; vaccine against AIDS;
D O I
10.1016/S0264-410X(97)00272-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccinology is the science and engineering of developing vaccines to prevent infectious diseases. Guidelines come from knowledge of pathogenesis and from successful past vaccines. The vaccine enterprise relies on the evolution of appropriate science and technology. Governmental support and industrial participation are key to successful development of new vaccines. A large challenge for vaccinology is a vaccine which protects against AIDS. Though misguided in its first decade, current vaccine research is directed to use of any and all viral antigens and to elicit both cell-mediated and humoral immune responses that are resident, with memory, at the mucosal sites of viral entry. Recent seminal discoveries guiding the future include selective elicitation of both Type 1 and Type 2 immune responses, and prime-boosting using recombinant viral or DNA vectors and expressed antigens. Success in vaccinology depends on simplification of the complex and on iterative processes in a well-defined pathway. The present and future of vaccinology are discussed in depth. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:778 / 793
页数:16
相关论文
共 71 条
  • [1] ANNUNZIATO D, 1982, PEDIATRICS, V70, P203
  • [2] Evolution and plasticity of CTL responses against HIV
    Autran, B
    Hadida, F
    Haas, G
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (04) : 546 - 553
  • [3] Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis
    Auwaerter, PG
    Kaneshima, H
    McCune, JM
    Wiegand, G
    Griffin, DE
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (06) : 3734 - 3740
  • [4] Changes within T cell receptor V-beta subsets in infants following measles vaccination
    Auwaerter, PG
    Hussey, GD
    Goddard, EA
    Hughes, J
    Ryon, JJ
    Strebel, PM
    Beatty, D
    Griffin, DE
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 79 (02): : 163 - 170
  • [5] Fighting HIV-1 with IL-16
    Baier, M
    Kurth, R
    [J]. NATURE MEDICINE, 1997, 3 (06) : 605 - 606
  • [6] Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor
    Baier, M
    Bannert, N
    Werner, A
    Lang, K
    Kurth, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) : 5273 - 5277
  • [7] Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection
    BaierBitterlich, G
    Fuchs, D
    Wachter, H
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 53 (06) : 755 - 763
  • [8] Vaccination with HIV 1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit
    Barnett, SW
    Rajasekar, S
    Legg, H
    Doe, B
    Fuller, DH
    Haynes, JR
    Walker, CM
    Steimer, KS
    [J]. VACCINE, 1997, 15 (08) : 869 - 873
  • [9] Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
    Borrow, P
    Lewicki, H
    Wei, XP
    Horwitz, MS
    Peffer, N
    Meyers, H
    Nelson, JA
    Gairin, JE
    Hahn, BH
    Oldstone, MBA
    Shaw, GM
    [J]. NATURE MEDICINE, 1997, 3 (02) : 205 - 211
  • [10] Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
    Boyer, JD
    Ugen, KE
    Wang, B
    Agadjanyan, M
    Gilbert, L
    Bagarazzi, ML
    Chattergoon, M
    Frost, P
    Javadian, A
    Williams, WV
    Refaeli, Y
    Ciccarelli, RB
    McCallus, D
    Coney, L
    Weiner, DB
    [J]. NATURE MEDICINE, 1997, 3 (05) : 526 - 532